Hong Chen

ORCID: 0000-0003-2805-5428
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • MicroRNA in disease regulation
  • Circular RNAs in diseases
  • Peroxisome Proliferator-Activated Receptors
  • Atherosclerosis and Cardiovascular Diseases
  • Cancer-related molecular mechanisms research
  • Inflammasome and immune disorders
  • Prion Diseases and Protein Misfolding
  • COVID-19 Clinical Research Studies
  • Homelessness and Social Issues
  • Livestock and Poultry Management
  • Hepatitis B Virus Studies
  • Adipokines, Inflammation, and Metabolic Diseases
  • Animal Genetics and Reproduction
  • Lipoproteins and Cardiovascular Health
  • Cancer, Lipids, and Metabolism
  • Health disparities and outcomes
  • Sleep and Work-Related Fatigue
  • Health and Wellbeing Research
  • Phytochemistry and Biological Activities
  • Housing, Finance, and Neoliberalism
  • Drug-Induced Hepatotoxicity and Protection
  • Biomarkers in Disease Mechanisms
  • Silymarin and Mushroom Poisoning
  • Cholesterol and Lipid Metabolism
  • Neurological diseases and metabolism

University of Southern California
2023

Public Health Clinical Center of Chengdu
2020

Peking University
2008-2019

Peking University People's Hospital
2008-2019

Shanghai Jiao Tong University
2015

MRC Laboratory of Molecular Biology
2011

Jiangsu Normal University
2007

Changhai Hospital
1992

Second Military Medical University
1992

Statin therapy plays a pivotal role in stabilizing the plaque for unstable angina (UA) patients although its mechanism(s) remains largely unexplored. Here we aim to identify microRNAs (miRNAs) mediating protective effect of statins UA patients. MiRNAs Array was carried out compare circulating whole blood miRNA profile treated with (n = 10) and without statin plasma 5) 5). 22 miRNAs 19 were found significantly upregulated group. Targets these predicted by algoritms: Targetscan, Miranda Diana...

10.1186/s12920-015-0082-4 article EN cc-by BMC Medical Genomics 2015-03-12

10.1016/j.jacc.2014.06.303 article EN publisher-specific-oa Journal of the American College of Cardiology 2014-10-01

OBJECTIVE: To describe the characteristics of liver damage in severe coronavirus disease 2019 (COVID-19) patients Sichuan area and effect antiviral drugs on function METHODS: The clinical data COVID-19 admitted to Chengdu Public Health Clinical Medical Center from January 21 February 24, 2020 were retrospectively collected, including demographic data, manifestations changes within 1 week after admission intensive care unit (ICU) during course analyzed summarized, group analysis was performed...

10.3760/cma.j.cn121430-20200513-00656 article EN Zhonghua weizhongbing jijiu yixue 2020-08-01
Coming Soon ...